Skip to content
healthcare.dev

RETHYMIC

NDC 72359-001, allogenic thymocyte-depleted thymus tissue-agdc, implant, from Sumitomo Pharma America, Inc..

Product NDC
72359-001
Status
Listed
Labeler
Sumitomo Pharma America, Inc.
Dosage form
IMPLANT
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125685
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72359-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALLOGENEIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC22000 mm/1
Package NDCNDC-11Package
72359-001-017235900010111 CONTAINER in 1 BOX (72359-001-01) / 4 IMPLANT in 1 CONTAINER (72359-001-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e0022c28-8cda-4f1e-bcf1-1f440d37ec4a

Use it

Look up 72359-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72359-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72359-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.